BRIEF published on 04/07/2025 at 20:19, 11 months 16 days ago GenSight Biologics Financial and Business Update Fundraising Clinical Trials Gene Therapy Financial Update GenSight Biologics
BRIEF published on 04/07/2025 at 20:19, 11 months 16 days ago Mise à jour financière et commerciale de GenSight Biologics Essais Cliniques Thérapie Génique Mise À Jour Financière Collecte De Fonds GenSight Biologics
PRESS RELEASE published on 04/07/2025 at 20:14, 11 months 16 days ago Inside Information / News release on accounts, results GenSight Biologics reports cash position and business update as of March 31, 2025. Discussions with French agency progressing. Fundraising planned for Phase III trial and marketing advancement Business Update Cash Position Fundraising Activities GenSight Biologics RECOVER Phase III Trial
PRESS RELEASE published on 04/07/2025 at 20:14, 11 months 16 days ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation de trésorerie au 31 mars 2025, annonce des activités de levées de fonds pour prolonger l'horizon de trésorerie et fait le point sur ses activités Trésorerie Essai Clinique GenSight Biologics Thérapies Géniques Levées De Fonds
BRIEF published on 03/17/2025 at 07:35, 1 year ago GenSight Biologics Présente LUMEVOQ® au Congrès NANOS 2025 Thérapie Génique GenSight Biologics LUMEVOQ® NOHL Congrès NANOS
BRIEF published on 03/17/2025 at 07:35, 1 year ago GenSight Biologics Presents LUMEVOQ® at NANOS 2025 Gene Therapy GenSight Biologics LUMEVOQ® NOHL NANOS Congress
PRESS RELEASE published on 03/17/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués GenSight Biologics annonce des communications scientifiques sur LUMEVOQ® au Congrès 2025 du NANOS. Nouvelles données sur la thérapie génique pour NOHL Thérapie Génique GenSight Biologics NOHL LUMEVOQ NEURO-OPHTALMOLOGIE
PRESS RELEASE published on 03/17/2025 at 07:30, 1 year ago Inside Information / Other news releases GenSight Biologics will present scientific updates on LUMEVOQ gene therapy at NANOS 2025, including real-world experience and long-term outcomes for LHON treatment Gene Therapy GenSight Biologics LHON LUMEVOQ NANOS 2025
BRIEF published on 03/07/2025 at 08:34, 1 year ago GenSight Biologics Secures €0.9 Million Financing from Existing Investors Investors Financing Gene Therapy GenSight Biologics Retinal Diseases
BRIEF published on 03/07/2025 at 08:34, 1 year ago GenSight Biologics obtient un financement de 0,9 million d'euros auprès d'investisseurs existants Financement Investisseurs Thérapie Génique GenSight Biologics Maladies De La Rétine
Published on 03/23/2026 at 22:40, 1 hour 29 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 1 hour 39 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 2 hours 9 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 2 hours 51 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 10 hours 4 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 22:05, 2 hours 4 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 3 hours 4 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 3 hours 4 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 3 hours 9 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 3 hours 14 minutes ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 5 hours 1 minute ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 5 hours 1 minute ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 5 hours 32 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 6 hours 24 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 6 hours 24 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
